Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

105.69 1.16 −1.09%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100

Zimmer Biomet Holdings, Inc. (ZBH) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/EBITDA of 12.1×. Over the past ten years it has ranged from 9.9× (May 2026) to 31.6× (November 2015); the current reading is higher than 15% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.3× (5.10%)
FY2024 11.9× (13.62%)
FY2023 13.8× (17.60%)
FY2022 16.7× (7.28%)
FY2021 18.0× (30.74%)
FY2020 26.0× 52.66%
FY2019 17.0× 20.26%
FY2018 14.2× (9.10%)
FY2017 15.6× (4.52%)
FY2016 16.3× (33.04%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 10.6× 3.77%
Jun 2026 10.2× (5.35%)
Mar 2026 10.8× (4.42%)
Dec 2025 11.3× 3.10%
43 more quarters

Against its own ten years

Low 9.9× High 31.6×
Ten-year median 15.9×
Current reading's percentile 15

EV/EBITDA against peers

Company EV/EBITDA
GKOS Glaukos Corporation compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
PHG Koninklijke Philips N.V. compare 11.1×
GMED Globus Medical, Inc. compare 11.9×
ZBH Zimmer Biomet Holdings, Inc. 12.1×
STE STERIS plc compare 15.7×
PODD Insulet Corporation compare 16.1×
DXCM DexCom, Inc. compare 21.2×
PEN Penumbra, Inc. compare 57.3×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ZBH